Ticker: SLNO

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is a biopharmaceutical company focused on developing treatments for rare diseases. The company recently achieved a pivotal milestone with the FDA's approval of its lead product, VYKAT XR, intended to treat hyperphagia in Prader-Willi syndrome patients. Rev...